<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02510105</url>
  </required_header>
  <id_info>
    <org_study_id>CHU-0236</org_study_id>
    <nct_id>NCT02510105</nct_id>
  </id_info>
  <brief_title>Tomodensitometric Study of Pulmonary Effects of Intrapulmonary Percussive Ventilation in ARDS Patients</brief_title>
  <acronym>PERVE-ARDS</acronym>
  <official_title>Tomodensitometric Study of Pulmonary Effects of Intrapulmonary Percussive Ventilation in ARDS Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Estaing</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <brief_summary>
    <textblock>
      The study is intended to elucidate the pulmonary effects of Intrapulmonary Percussive&#xD;
      Ventilation (IPV) with VDR4 ventilator of patients with ARDS, using computed tomography (CT).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective clinical study in ICU of ventilated patients with ARDS. The morphologic pulmonary&#xD;
      effects of IPV with VDR4 are not known to the investigators' knowledge.&#xD;
&#xD;
      The main aim is to quantify recruited, normally aerated and overinflated parts of the lungs&#xD;
      after a 1 hour treatment with IPV.&#xD;
&#xD;
      Patients with ARDS (focal and non focal) consecutively admitted to the investigators' ICU are&#xD;
      enrolled after informed consent.&#xD;
&#xD;
      Patients are intubated and ventilated with Servo-I (GE) and ventilation is optimized&#xD;
      according to ARDS-network recommandations.&#xD;
&#xD;
      A first thoracic CT-scan is performed with ICU ventilator and then the patient is ventilated&#xD;
      with VDR4 during 1 hour.&#xD;
&#xD;
      A second thoracic CT-scan is then performed and the patient re-ventilated with ICU&#xD;
      ventilator.&#xD;
&#xD;
      Arterial blood gases and hemodynamic parameters are recorded during experiments.&#xD;
&#xD;
      CT-scan are analysed and compared for normally aerated, overinflated and recruited lung&#xD;
      parenchyma. Regions are determined thanks to their Hounsfield units (HU).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline (H0) in volume of overinflated lung at H1</measure>
    <time_frame>at Hour 0(just before Intrapulmonary Percussive Ventilation) and Hour 1(just after Intrapulmonary Percussive Ventilation)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Volume of normally aerated lung</measure>
    <time_frame>at Hour 0 (just before Intrapulmonary Percussive Ventilation ) and Hour 1 (just after Intrapulmonary Percussive Ventilation)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume of recruited lung</measure>
    <time_frame>at day 1 (between H0 and H1)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>at day 1 ((every 10 min between H0 and H1)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>at day 1 (every 10 min between H0 and H1)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial blood gaz</measure>
    <time_frame>at day 1 ((every 10 min between H0 and H1)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evolution of catecholamine doses (Âµg/Kg/min)</measure>
    <time_frame>at day 1 (every 10 min between H0 and H1)</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>ARDS</condition>
  <arm_group>
    <arm_group_label>ARDS patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VDR4 ventilator (Intrapulmonary Percussive Ventilation)</intervention_name>
    <arm_group_label>ARDS patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CT scan</intervention_name>
    <arm_group_label>ARDS patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Servo-i</intervention_name>
    <arm_group_label>ARDS patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>- Intubation</intervention_name>
    <arm_group_label>ARDS patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ventilation ( with an ICU conventional ventilator)</intervention_name>
    <arm_group_label>ARDS patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients ventilated more than 48 h&#xD;
&#xD;
          -  Sedated patients&#xD;
&#xD;
          -  ARDS moderate or severe (Berlin 2012)&#xD;
&#xD;
          -  Patients who have given their consent or his family&#xD;
&#xD;
          -  Patients aged between 18 and 85 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant ou lactating women&#xD;
&#xD;
          -  Hemodynamic instability&#xD;
&#xD;
          -  Chronic respiratory insufficiency.&#xD;
&#xD;
          -  Pneumothorax&#xD;
&#xD;
          -  Fistulae bronchopleural&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Michel CONSTANTIN</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Clermont-Ferrand</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patrick LACARIN</last_name>
    <phone>04 73 75 11 95</phone>
    <email>placarin@chu-clermontferrand.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Patrick LACARIN</last_name>
      <phone>04 73 75 11 95</phone>
      <email>placarin@chu-clermontferrand.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Michel CONSTANTIN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <study_first_submitted>June 1, 2015</study_first_submitted>
  <study_first_submitted_qc>July 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 28, 2015</study_first_posted>
  <last_update_submitted>July 27, 2015</last_update_submitted>
  <last_update_submitted_qc>July 27, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Critical Care</keyword>
  <keyword>ARDS</keyword>
  <keyword>Intrapulmonary Percussive Ventilation</keyword>
  <keyword>VDR4</keyword>
  <keyword>Lung aeration</keyword>
  <keyword>CT scan</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

